SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 70 filers reported holding SYROS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,829,000 | -19.1% | 1,900,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $2,261,000 | -63.5% | 1,900,000 | 0.0% | 0.00% | -63.6% |
| Q4 2021 | $6,194,000 | -23.0% | 1,900,000 | +5.6% | 0.01% | -31.2% |
| Q3 2021 | $8,046,000 | +73.2% | 1,800,000 | +111.2% | 0.02% | +77.8% |
| Q2 2021 | $4,645,000 | – | 852,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 881,450 | $5,677,000 | 1.32% |
| IFP Advisors, Inc | 50 | $1,000 | 0.00% |
| Ten Capital Wealth Advisors, LLC | 219 | $1,000 | 0.00% |